{"id":14320,"date":"2023-12-19T07:19:02","date_gmt":"2023-12-19T07:19:02","guid":{"rendered":"https:\/\/dev.sunpharma.com\/?page_id=14320"},"modified":"2025-11-24T12:44:47","modified_gmt":"2025-11-24T07:14:47","slug":"composite-scheme-of-arrangement","status":"publish","type":"page","link":"https:\/\/dev.sunpharma.com\/he\/composite-scheme-of-arrangement\/","title":{"rendered":"Composite Scheme of Arrangement"},"content":{"rendered":"<p>[et_pb_section fb_built=&#8221;1&#8243; fullwidth=&#8221;on&#8221; _builder_version=&#8221;4.16&#8243; parallax=&#8221;on&#8221; animation_style=&#8221;fade&#8221; da_disable_devices=&#8221;off|off|off&#8221; saved_tabs=&#8221;all&#8221; locked=&#8221;off&#8221; collapsed=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221; da_is_popup=&#8221;off&#8221; da_exit_intent=&#8221;off&#8221; da_has_close=&#8221;on&#8221; da_alt_close=&#8221;off&#8221; da_dark_close=&#8221;off&#8221; da_not_modal=&#8221;on&#8221; da_is_singular=&#8221;off&#8221; da_with_loader=&#8221;off&#8221; da_has_shadow=&#8221;on&#8221;][et_pb_fullwidth_header title=&#8221;Scheme of Arrangement&#8221; header_fullscreen=&#8221;on&#8221; button_one_url=&#8221;https:\/\/sun.stagingservice.net\/quality\/&#8221; button_two_url=&#8221;https:\/\/sun.stagingservice.net\/innovation\/&#8221; _builder_version=&#8221;4.16&#8243; title_font=&#8221;|700|||||||&#8221; title_text_color=&#8221;#f7941e&#8221; title_font_size=&#8221;35px&#8221; title_line_height=&#8221;1.2em&#8221; content_font=&#8221;||||||||&#8221; content_text_color=&#8221;#000000&#8243; content_font_size=&#8221;18px&#8221; content_line_height=&#8221;1.8em&#8221; subhead_font=&#8221;||||||||&#8221; subhead_text_color=&#8221;rgba(0,0,0,0.6)&#8221; subhead_font_size=&#8221;22px&#8221; background_color=&#8221;rgba(255,255,255,0.8)&#8221; custom_button_one=&#8221;on&#8221; button_one_text_size=&#8221;20px&#8221; button_one_text_color=&#8221;#ffffff&#8221; button_one_bg_color=&#8221;#f7941e&#8221; button_one_border_width=&#8221;0px&#8221; button_one_font=&#8221;|||on|||||&#8221; button_one_use_icon=&#8221;off&#8221; custom_button_two=&#8221;on&#8221; button_two_text_size=&#8221;20px&#8221; button_two_text_color=&#8221;rgba(0,0,0,0.7)&#8221; button_two_bg_color=&#8221;#ffffff&#8221; button_two_border_width=&#8221;0px&#8221; button_two_font=&#8221;|||on|||||&#8221; button_two_use_icon=&#8221;off&#8221; button_two_custom_margin=&#8221;||||false|false&#8221; button_two_custom_margin_tablet=&#8221;&#8221; button_two_custom_margin_phone=&#8221;|||1px|false|false&#8221; button_two_custom_margin_last_edited=&#8221;on|desktop&#8221; button_two_custom_padding=&#8221;||||false|false&#8221; background_layout=&#8221;light&#8221; width=&#8221;50%&#8221; width_tablet=&#8221;&#8221; width_phone=&#8221;100%&#8221; width_last_edited=&#8221;on|phone&#8221; animation_style=&#8221;fade&#8221; animation_duration=&#8221;500ms&#8221; animation_delay=&#8221;300ms&#8221; title_font_tablet=&#8221;&#8221; title_font_phone=&#8221;&#8221; title_font_last_edited=&#8221;on|phone&#8221; content_font_tablet=&#8221;&#8221; content_font_phone=&#8221;&#8221; content_font_last_edited=&#8221;on|phone&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_fullwidth_header][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; da_disable_devices=&#8221;off|off|off&#8221; global_colors_info=&#8221;{}&#8221; da_is_popup=&#8221;off&#8221; da_exit_intent=&#8221;off&#8221; da_has_close=&#8221;on&#8221; da_alt_close=&#8221;off&#8221; da_dark_close=&#8221;off&#8221; da_not_modal=&#8221;on&#8221; da_is_singular=&#8221;off&#8221; da_with_loader=&#8221;off&#8221; da_has_shadow=&#8221;on&#8221;][et_pb_row _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; width=&#8221;90%&#8221; max_width=&#8221;2560px&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; header_text_color=&#8221;#F7941E&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h2 style=\"font-weight: bold; font-size: 25px; color: #6e7071; !important; line-height: 1.2em;\">Composite Scheme of Arrangement involving Amalgamation of five Wholly-owned subsidiaries with the Company and Reclassification of General Reserve of the Company<\/h2>\n<p>[\/et_pb_text][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; hover_enabled=&#8221;0&#8243; global_colors_info=&#8221;{}&#8221; sticky_enabled=&#8221;0&#8243;]<a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2025\/11\/Intimatioto-SEEffective-dateScheme.pdf\">Intimation of Effective Date of the Composite Scheme of Arrangement<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2025\/10\/NCLT-Order-for-Composite-Scheme-of-Arrangement.pdf\"><span>NCLT Order for Composite Scheme of Arrangement<\/span><\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2025\/01\/CDSL_SUN_PHARMA_21-012025.mp4\"><span>Webcast Recording of NCLT Convened Meeting of the Shareholders of the Company<\/span><\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2025\/01\/OutcomeofNCLTMeeting.pdf\"><span>Outcome of the NCLT Convened Meeting of the Shareholders of the Company<\/span><\/a>[\/et_pb_text][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2025\/01\/Scrutinizers-Report_21-Jan-2025.pdf\">Scrutinizer\u2019s Consolidated Report for remote e-voting and e-voting at the NCLT Convened Meeting of the Members.<\/a>[\/et_pb_text][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2024\/12\/Sun-Pharma-Notice-of-NCLT-Convened-Meeting-on-Jan-21-2025.pdf\">Sun Pharma &#8211; Notice of NCLT Convened Meeting on Jan 21, 2025<\/a>[\/et_pb_text][et_pb_code _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<!DOCTYPE html><!-- [et_pb_line_break_holder] --><html lang=\"en\"><!-- [et_pb_line_break_holder] --><head><!-- [et_pb_line_break_holder] -->    <link href='https:\/\/fonts.googleapis.com\/css?family=Lato' rel='stylesheet'><!-- [et_pb_line_break_holder] -->    <meta charset=\"UTF-8\"><!-- [et_pb_line_break_holder] -->    <meta name=\"viewport\" content=\"width=device-width, initial-scale=1.0\"><!-- [et_pb_line_break_holder] -->    <title>Additional Information Submitted to Stock Exchanges<\/title><!-- [et_pb_line_break_holder] -->    <\/p>\n<style><!-- [et_pb_line_break_holder] -->        .stock {<!-- [et_pb_line_break_holder] -->            font-family: 'Lato';<!-- [et_pb_line_break_holder] -->            color: white;<!-- [et_pb_line_break_holder] -->            display: flex;<!-- [et_pb_line_break_holder] -->            justify-content: center;<!-- [et_pb_line_break_holder] -->            align-items: center;<!-- [et_pb_line_break_holder] -->            height: 100vh;<!-- [et_pb_line_break_holder] -->            margin: 0;<!-- [et_pb_line_break_holder] -->            padding: 0 10px;<!-- [et_pb_line_break_holder] -->            box-sizing: border-box;<!-- [et_pb_line_break_holder] -->        }<!-- [et_pb_line_break_holder] --><!-- [et_pb_line_break_holder] -->        .container-stock {<!-- [et_pb_line_break_holder] -->            text-align: center;<!-- [et_pb_line_break_holder] -->            \/*padding: 20px;*\/<!-- [et_pb_line_break_holder] -->            border-radius: 0px;<!-- [et_pb_line_break_holder] -->            width: 100%;<!-- [et_pb_line_break_holder] -->            max-width: 100%;<!-- [et_pb_line_break_holder] -->        }<!-- [et_pb_line_break_holder] --><!-- [et_pb_line_break_holder] -->        \/* Hide the input checkboxes *\/<!-- [et_pb_line_break_holder] -->        input[type=\"checkbox\"] {<!-- [et_pb_line_break_holder] -->            display: none;<!-- [et_pb_line_break_holder] -->        }<!-- [et_pb_line_break_holder] --><!-- [et_pb_line_break_holder] -->        \/* Title for toggling *\/<!-- [et_pb_line_break_holder] -->        .title-label {<!-- [et_pb_line_break_holder] -->            display: block;<!-- [et_pb_line_break_holder] -->            font-size: 16px;<!-- [et_pb_line_break_holder] -->            font-weight: 300;<!-- [et_pb_line_break_holder] -->            color: #F7941E;<!-- [et_pb_line_break_holder] -->            cursor: pointer;<!-- [et_pb_line_break_holder] -->            margin-bottom: 20px;<!-- [et_pb_line_break_holder] -->            text-align: left;<!-- [et_pb_line_break_holder] -->        }<!-- [et_pb_line_break_holder] --><!-- [et_pb_line_break_holder] -->        \/* Label for toggling BSE and NSE *\/<!-- [et_pb_line_break_holder] -->        .column-title {<!-- [et_pb_line_break_holder] -->            display: block;<!-- [et_pb_line_break_holder] -->            font-size: 18px;<!-- [et_pb_line_break_holder] -->            font-weight: 500;<!-- [et_pb_line_break_holder] -->            background-color: #f7941e;<!-- [et_pb_line_break_holder] -->            padding: 10px;<!-- [et_pb_line_break_holder] -->            color: white;<!-- [et_pb_line_break_holder] -->            cursor: pointer;<!-- [et_pb_line_break_holder] -->            text-align: center;<!-- [et_pb_line_break_holder] -->            border-radius: 0px;<!-- [et_pb_line_break_holder] -->        }<!-- [et_pb_line_break_holder] --><!-- [et_pb_line_break_holder] -->        \/* Show menustock when the main checkbox is checked *\/<!-- [et_pb_line_break_holder] -->        input[type=\"checkbox\"]:checked + .title-label + .menustock {<!-- [et_pb_line_break_holder] -->            display: flex;<!-- [et_pb_line_break_holder] -->        }<!-- [et_pb_line_break_holder] --><!-- [et_pb_line_break_holder] -->        \/* Show substockme when individual checkboxes are checked *\/<!-- [et_pb_line_break_holder] -->        input[type=\"checkbox\"]:checked + .column-title + .substockme {<!-- [et_pb_line_break_holder] -->            display: block;<!-- [et_pb_line_break_holder] -->        }<!-- [et_pb_line_break_holder] --><!-- [et_pb_line_break_holder] -->        .menustock {<!-- [et_pb_line_break_holder] -->            display: none;<!-- [et_pb_line_break_holder] -->            flex-direction: column;<!-- [et_pb_line_break_holder] -->            gap: 20px;<!-- [et_pb_line_break_holder] -->        }<!-- [et_pb_line_break_holder] --><!-- [et_pb_line_break_holder] -->        .column {<!-- [et_pb_line_break_holder] -->            flex: 1;<!-- [et_pb_line_break_holder] -->             text-align: center;<!-- [et_pb_line_break_holder] -->            \/*padding: 15px;<!-- [et_pb_line_break_holder] -->            border: 1px solid #0000001a;*\/<!-- [et_pb_line_break_holder] -->            border-radius: 0px;<!-- [et_pb_line_break_holder] -->        }<!-- [et_pb_line_break_holder] --><!-- [et_pb_line_break_holder] -->        \/* Display BSE and NSE in a single row on desktop *\/<!-- [et_pb_line_break_holder] -->        @media (min-width: 768px) {<!-- [et_pb_line_break_holder] -->            .menustock {<!-- [et_pb_line_break_holder] -->                flex-direction: row;<!-- [et_pb_line_break_holder] -->            }<!-- [et_pb_line_break_holder] -->        }<!-- [et_pb_line_break_holder] --><!-- [et_pb_line_break_holder] -->        .substockme {<!-- [et_pb_line_break_holder] -->            display: none;<!-- [et_pb_line_break_holder] -->            margin-top: 10px;<!-- [et_pb_line_break_holder] -->            <!-- [et_pb_line_break_holder] -->            border-radius: 0px;<!-- [et_pb_line_break_holder] -->        }<!-- [et_pb_line_break_holder] --><!-- [et_pb_line_break_holder] -->        .substockme a {<!-- [et_pb_line_break_holder] -->            display: block;<!-- [et_pb_line_break_holder] -->            padding: 10px;<!-- [et_pb_line_break_holder] -->            background-color: #8d8d8c;<!-- [et_pb_line_break_holder] -->            margin: 5px 0;<!-- [et_pb_line_break_holder] -->            text-decoration: none;<!-- [et_pb_line_break_holder] -->            color: white;<!-- [et_pb_line_break_holder] -->            text-align: center;<!-- [et_pb_line_break_holder] -->            border-radius: 0px;<!-- [et_pb_line_break_holder] -->        }<!-- [et_pb_line_break_holder] --><!-- [et_pb_line_break_holder] -->        .substockme a:hover {<!-- [et_pb_line_break_holder] -->            background-color: #000;<!-- [et_pb_line_break_holder] -->            color: white;<!-- [et_pb_line_break_holder] -->        }<!-- [et_pb_line_break_holder] -->    <\/style>\n<p><!-- [et_pb_line_break_holder] --><\/head><!-- [et_pb_line_break_holder] --><body data-rsssl=1 data-rsssl=1 data-rsssl=1 data-rsssl=1 data-rsssl=1 class=\"stock\"><!-- [et_pb_line_break_holder] --><!-- [et_pb_line_break_holder] --><\/p>\n<div class=\"container-stock\"><!-- [et_pb_line_break_holder] -->    <!-- Toggle the entire menustock --><!-- [et_pb_line_break_holder] -->    <input type=\"checkbox\" id=\"togglemenustock\"><!-- [et_pb_line_break_holder] -->    <label for=\"togglemenustock\" class=\"title-label\">Additional information submitted to Stock Exchanges<\/label><!-- [et_pb_line_break_holder] --><!-- [et_pb_line_break_holder] -->    <\/p>\n<div class=\"menustock\"><!-- [et_pb_line_break_holder] -->        <!-- BSE Section --><!-- [et_pb_line_break_holder] -->        <\/p>\n<div class=\"column\"><!-- [et_pb_line_break_holder] -->            <input type=\"checkbox\" id=\"bseToggle\"><!-- [et_pb_line_break_holder] -->            <label for=\"bseToggle\" class=\"column-title\">BSE<\/label><!-- [et_pb_line_break_holder] -->            <\/p>\n<div class=\"substockme\"><!-- [et_pb_line_break_holder] -->                <a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2024\/12\/7-December-2023.pdf\" target=\"_blank\" rel=\"noopener\">7 December 2023<\/a><!-- [et_pb_line_break_holder] -->                <a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2024\/12\/15-December-2023.pdf\" target=\"_blank\" rel=\"noopener\">15 December 2023<\/a><!-- [et_pb_line_break_holder] -->                <a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2024\/12\/20-December-2023.pdf\" target=\"_blank\" rel=\"noopener\">20 December 2023<\/a><!-- [et_pb_line_break_holder] -->                <a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2024\/12\/5-February-2024.pdf\" target=\"_blank\" rel=\"noopener\">5 February 2024<\/a><!-- [et_pb_line_break_holder] -->                <a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2024\/12\/23-May-2024.pdf\" target=\"_blank\" rel=\"noopener\">23 May 2024<\/a><!-- [et_pb_line_break_holder] -->            <\/div>\n<p><!-- [et_pb_line_break_holder] -->        <\/div>\n<p><!-- [et_pb_line_break_holder] --><!-- [et_pb_line_break_holder] -->        <!-- NSE Section --><!-- [et_pb_line_break_holder] -->        <\/p>\n<div class=\"column\"><!-- [et_pb_line_break_holder] -->            <input type=\"checkbox\" id=\"nseToggle\"><!-- [et_pb_line_break_holder] -->            <label for=\"nseToggle\" class=\"column-title\">NSE<\/label><!-- [et_pb_line_break_holder] -->            <\/p>\n<div class=\"substockme\"><!-- [et_pb_line_break_holder] -->                <a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2024\/12\/1-December-2023-NSE.pdf\" target=\"_blank\" rel=\"noopener\">1 December 2023<\/a><!-- [et_pb_line_break_holder] -->                <a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2024\/12\/7-December-2023-NSE.pdf\" target=\"_blank\" rel=\"noopener\">7 December 2023<\/a><!-- [et_pb_line_break_holder] -->                <a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2024\/12\/19-December-2023-NSE.pdf\" target=\"_blank\" rel=\"noopener\">19 December 2023<\/a><!-- [et_pb_line_break_holder] -->                <a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2024\/12\/22-December-2023-NSE.pdf\" target=\"_blank\" rel=\"noopener\">22 December 2023<\/a><!-- [et_pb_line_break_holder] -->                <a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2024\/12\/20-March-2024-NSE.pdf\" target=\"_blank\" rel=\"noopener\">20 March 2024<\/a><!-- [et_pb_line_break_holder] -->                <a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2024\/12\/26-August-2024-NSE.pdf\" target=\"_blank\" rel=\"noopener\">26 August 2024<\/a><!-- [et_pb_line_break_holder] -->            <\/div>\n<p><!-- [et_pb_line_break_holder] -->        <\/div>\n<p><!-- [et_pb_line_break_holder] -->    <\/div>\n<p><!-- [et_pb_line_break_holder] --><\/div>\n<p><!-- [et_pb_line_break_holder] --><!-- [et_pb_line_break_holder] --><\/body><!-- [et_pb_line_break_holder] --><\/html><!-- [et_pb_line_break_holder] -->[\/et_pb_code][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2024\/07\/BSE_Observation-letter-for-Scheme-of-Arrangement_24.06.2024.pdf\">BSE Observation Letter for Composite Scheme of Arrangement<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2024\/07\/NSE_Observation-letter-for-Scheme-of-Arrangement_24.06.2024.pdf\">NSE Observation Letter for Composite Scheme of Arrangement<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2024\/12\/Undertaking-to-SEBI.pdf\">Undertaking to SEBI<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2024\/04\/1.-Draft-Scheme-of-Arrangement.pdf\">Draft Scheme of Arrangement<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2024\/04\/2.-Certificate-for-non-applicability-of-valuation-report.pdf\">Certificate for non applicability of valuation report<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2024\/04\/3.-Audit-Committee-Report.pdf\">Audit Committee Report<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2024\/04\/4.-Shareholding-Pattern-Pre-and-Post-of-unlisted-entities.pdf\">Shareholding Pattern Pre and Post of unlisted entities<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2024\/04\/5.-Audited-Financials-of-last-3-years-of-unlisted-entities.pdf\">Audited Financials of last 3 years of unlisted entities<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2024\/04\/6.-Accounting-treatment-Certificate.pdf\">Accounting treatment Certificate<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2024\/04\/7.-Compliance-Report.pdf\">Compliance Report<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2024\/04\/8.-ID-Committee-Report.pdf\">ID Committee Report<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2024\/04\/9.-Past-Default-of-listed-debt-obligation.pdf\">Past Default of listed debt obligation<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2024\/04\/10.-NOC.pdf\">NOC<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2024\/04\/11.-Undertaking-certified-by-Auditor_Para-10.pdf\">Undertaking certified by Auditor_Para 10<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2024\/04\/12.-ReportonComplaints.pdf\">Report on Complaints<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2024\/04\/13.-NSEReportonComplaints15042024.pdf\">NSE Report on Complaints<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2024\/12\/1.-MOA-AOA-of-Sun-Pharmaceutical-Medicare-Ltd.pdf\">MOA &amp; AOA of Sun Pharmaceutical Medicare Limited<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2025\/01\/MOA-AOA-of-Green-Eco-Development-Centre-Limited.pdf\">MOA &amp; AOA of Green Eco Development Centre Limited<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2024\/12\/3.-MOA-AOA-of-Faststone-Mercantile-Company-Pvt-Ltd.pdf\">MOA &amp; AOA of Faststone Mercantile Company Private Limited<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2024\/12\/4.-MOA-AOA-of-Realstone-Multitrade-Pvt-Ltd.pdf\">MOA &amp; AOA of Realstone Multitrade Private Limited<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2024\/12\/5.-MOA-AOA-of-Skisen-Labs-Pvt-Ltd.pdf\">MOA &amp; AOA Skisen Labs Private Limited<\/a>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Composite Scheme of Arrangement involving Amalgamation of five Wholly-owned subsidiaries with the Company and Reclassification of General Reserve of the CompanyIntimation of Effective Date of the Composite Scheme of Arrangement NCLT Order for Composite Scheme of Arrangement Webcast Recording of NCLT Convened Meeting of the Shareholders of the Company Outcome of the NCLT Convened Meeting [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","inline_featured_image":false,"_uf_show_specific_survey":0,"_uf_disable_surveys":false,"footnotes":""},"class_list":["post-14320","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Composite Scheme of Arrangement - Sun Pharmaceutical Industries Ltd.<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/dev.sunpharma.com\/he\/composite-scheme-of-arrangement\/\" \/>\n<meta property=\"og:locale\" content=\"he_IL\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Composite Scheme of Arrangement - Sun Pharmaceutical Industries Ltd.\" \/>\n<meta property=\"og:description\" content=\"Composite Scheme of Arrangement involving Amalgamation of five Wholly-owned subsidiaries with the Company and Reclassification of General Reserve of the CompanyIntimation of Effective Date of the Composite Scheme of Arrangement NCLT Order for Composite Scheme of Arrangement Webcast Recording of NCLT Convened Meeting of the Shareholders of the Company Outcome of the NCLT Convened Meeting [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/dev.sunpharma.com\/he\/composite-scheme-of-arrangement\/\" \/>\n<meta property=\"og:site_name\" content=\"Sun Pharmaceutical Industries Ltd.\" \/>\n<meta property=\"article:modified_time\" content=\"2025-11-24T07:14:47+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"4 \u05d3\u05e7\u05d5\u05ea\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/dev.sunpharma.com\\\/composite-scheme-of-arrangement\\\/\",\"url\":\"https:\\\/\\\/dev.sunpharma.com\\\/composite-scheme-of-arrangement\\\/\",\"name\":\"Composite Scheme of Arrangement - Sun Pharmaceutical Industries Ltd.\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/dev.sunpharma.com\\\/#website\"},\"datePublished\":\"2023-12-19T07:19:02+00:00\",\"dateModified\":\"2025-11-24T07:14:47+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/dev.sunpharma.com\\\/composite-scheme-of-arrangement\\\/#breadcrumb\"},\"inLanguage\":\"he-IL\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/dev.sunpharma.com\\\/composite-scheme-of-arrangement\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/dev.sunpharma.com\\\/composite-scheme-of-arrangement\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/dev.sunpharma.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Composite Scheme of Arrangement\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/dev.sunpharma.com\\\/#website\",\"url\":\"https:\\\/\\\/dev.sunpharma.com\\\/\",\"name\":\"Sun Pharmaceutical Industries Ltd.\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/dev.sunpharma.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"he-IL\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Composite Scheme of Arrangement - Sun Pharmaceutical Industries Ltd.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/dev.sunpharma.com\/he\/composite-scheme-of-arrangement\/","og_locale":"he_IL","og_type":"article","og_title":"Composite Scheme of Arrangement - Sun Pharmaceutical Industries Ltd.","og_description":"Composite Scheme of Arrangement involving Amalgamation of five Wholly-owned subsidiaries with the Company and Reclassification of General Reserve of the CompanyIntimation of Effective Date of the Composite Scheme of Arrangement NCLT Order for Composite Scheme of Arrangement Webcast Recording of NCLT Convened Meeting of the Shareholders of the Company Outcome of the NCLT Convened Meeting [&hellip;]","og_url":"https:\/\/dev.sunpharma.com\/he\/composite-scheme-of-arrangement\/","og_site_name":"Sun Pharmaceutical Industries Ltd.","article_modified_time":"2025-11-24T07:14:47+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"4 \u05d3\u05e7\u05d5\u05ea"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/dev.sunpharma.com\/composite-scheme-of-arrangement\/","url":"https:\/\/dev.sunpharma.com\/composite-scheme-of-arrangement\/","name":"Composite Scheme of Arrangement - Sun Pharmaceutical Industries Ltd.","isPartOf":{"@id":"https:\/\/dev.sunpharma.com\/#website"},"datePublished":"2023-12-19T07:19:02+00:00","dateModified":"2025-11-24T07:14:47+00:00","breadcrumb":{"@id":"https:\/\/dev.sunpharma.com\/composite-scheme-of-arrangement\/#breadcrumb"},"inLanguage":"he-IL","potentialAction":[{"@type":"ReadAction","target":["https:\/\/dev.sunpharma.com\/composite-scheme-of-arrangement\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/dev.sunpharma.com\/composite-scheme-of-arrangement\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/dev.sunpharma.com\/"},{"@type":"ListItem","position":2,"name":"Composite Scheme of Arrangement"}]},{"@type":"WebSite","@id":"https:\/\/dev.sunpharma.com\/#website","url":"https:\/\/dev.sunpharma.com\/","name":"Sun Pharmaceutical Industries Ltd.","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/dev.sunpharma.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"he-IL"}]}},"_links":{"self":[{"href":"https:\/\/dev.sunpharma.com\/he\/wp-json\/wp\/v2\/pages\/14320","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dev.sunpharma.com\/he\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/dev.sunpharma.com\/he\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/dev.sunpharma.com\/he\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/dev.sunpharma.com\/he\/wp-json\/wp\/v2\/comments?post=14320"}],"version-history":[{"count":47,"href":"https:\/\/dev.sunpharma.com\/he\/wp-json\/wp\/v2\/pages\/14320\/revisions"}],"predecessor-version":[{"id":18229,"href":"https:\/\/dev.sunpharma.com\/he\/wp-json\/wp\/v2\/pages\/14320\/revisions\/18229"}],"wp:attachment":[{"href":"https:\/\/dev.sunpharma.com\/he\/wp-json\/wp\/v2\/media?parent=14320"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}